GlassScriptPhysician profile
Joseph I Hoffman
NPI 1588658421
$6,927.60
in general payments reported to CMS, 2019-2025
34 companies · $994 in 2025
The $994 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $255 · 2021: $515 · 2022: $1,753 · 2023: $687 · 2024: $644 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,193 · Long Term Medical Supply Or Device Loan: $77.59 · Education: $55.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,192.65 |
| Long Term Medical Supply Or Device Loan | $77.59 |
| Education | $55.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $1,242.52 | 2022-2025 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Johnson & Johnson Surgical Vision, INC. | $1,157.13 | 2019-2025 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Bausch & Lomb Americas INC. | $675.17 | 2022-2025 | Miebo, Xiidra, Envista Aspire Iol |
| Allergan, INC. | $646.82 | 2019-2022 | |
| Alcon Vision LLC | $591.76 | 2019-2025 | Tryptyr |
| Horizon Therapeutics Plc | $248.51 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $235.03 | 2019-2021 | |
| Biotissue Holdings INC. | $219.55 | 2019-2025 | |
| Aerie Pharmaceuticals, INC. | $196.48 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $190.37 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $177.16 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $144.63 | 2019 | |
| Abbvie INC. | $140.20 | 2022-2025 | |
| Omeros Corporation | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $119.90 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $110.68 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $77.59 | 2023 | Clarus |
| Oyster Point Pharma, INC. | $74.84 | 2022-2025 | Tyrvaya |
| Amgen INC. | $73.91 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $58.74 | 2023-2024 | Iyuzeh |
| Spark Therapeutics, INC. | $50.31 | 2021-2022 | |
| Dompe US, INC. | $47.82 | 2021-2024 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $41.87 | 2021-2022 | |
| Glaukos Corporation | $38.93 | 2024 | Radius |
| Rxsight INC | $34.06 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Gilead Sciences, INC. | $32.44 | 2023 | |
| Sight Sciences, INC. | $27.77 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $26.38 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
| Shire North American Group INC | $25.94 | 2019 | |
| Harrow Eye, LLC | $24.89 | 2025 | Vevye |
| Ortho-Clinical Diagnostics, INC. | $23.47 | 2025 | Inflammadry |
| Maculogix, INC. | $20.09 | 2019 | |
| Ocular Therapeutix, INC. | $14.78 | 2023 | Dextenza |
| Apellis Pharmaceuticals, INC. | $12.86 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.